The Canadian pharmaceutical market is projected to witness a compound annual growth rate (CAGR) of 2%, growing from $22.6bn in 2016 to $25bn by 2021, according to a report by GlobalData.

Titled ‘CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Canada’, the report profiles the pharmaceutical industry in Canada, which is one of the leading sites for clinical trials.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Increased investments from global pharmaceutical and biotechnology companies towards academic industrial translational activities has played a major role in driving growth in the country. In addition, clinical trials being carried out by pharmaceutical companies and the increase in elderly population is further driving growth.

Canada’s strong research and development (R&D) environment is now shifting towards externalised R&D, wherein the government is establishing partnerships and collaborations through programmes such as the Business-led Networks of Centres of Excellence (BL-NCEs), Centres of Excellence for Commercialization of Research (CECR), and the Structural Genomics Consortium.

"Sales of generic drugs were worth $6.2bn in 2016, which is 22.4% of the overall pharmaceutical market value."

Academic healthcare institutions, 17 medical schools, and approximately 13,600 researchers are involved in the R&D efforts. Pharmaceutical companies such as Johnson & Johnson and Teva have partnered with these institutions to take advantage of their quality and research expertise.

See Also:

Generic drugs account for 70% of prescriptions in Canada and saved approximately $20bn for the government in 2016.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Sales of generic drugs were worth $6.2bn in 2016, which is 22.4% of the overall pharmaceutical market value.

The market is expected to grow and expand further as the government continues to promote generics usage, the report adds.